Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging.

"FUNDING SOURCES: This work was supported by a Damon Runyon-Rachleff Innovation award (to D.G.K.), a joint American Cancer Society-Canary Foundation Postdoctoral Fellowship (to R.D.D.), and a Marble Foundation Grant awarded to the Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research.: CONFLICT OF INTEREST DISCLOSURES: W.D.L. is a cofounder and interim chief executive officer of Lumicell Diagnostics, Inc., a company that commercializes in vivo imaging systems. M.G.B. is a cofounder of Lumicell Diagnostics, Inc.; L.G.G. and D.G.K. are members of the Scientific Advisory Board of Lumicell Diagnostics, Inc.; and J.M.F. is a consultant for Lumicell Diagnostics, Inc."

"FUNDING SOURCES This work was supported by a Damon Runyon-Rachleff Innovation award (to D.G.K.), a joint American Cancer Society-Canary Foundation Postdoctoral Fellowship (to R.D.D.), and a Marble Foundation Grant awarded to the Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research. CONFLICT OF INTEREST DISCLOSURES W.D.L. is a cofounder and interim chief executive officer of Lumicell Diagnostics, Inc., a company that commercializes in vivo imaging systems. M.G.B. is a cofounder of Lumicell Diagnostics, Inc.; L.G.G. and D.G.K. are members of the Scientific Advisory Board of Lumicell Diagnostics, Inc.; and J.M.F. is a consultant for Lumicell Diagnostics, Inc."